Hundreds of patients to benefit from ‘two-minute’ cancer treatment
Patients in East Yorkshire and Northern Lincolnshire are to benefit from a formulation of a drug that is used in the treatment of 14 different types of cancer. Humber Health […]
‘1-minute’ immunotherapy jab rolled out on NHS for tens of thousands with cancer
Tens of thousands of patients could benefit from a ‘rapid’ new immunotherapy jab on the NHS for over a dozen different cancers, which can be given in just 60 seconds. […]
First-of-its-kind international trial launches to harness the immune system against childhood cancers
The first person has been enrolled in a new clinical trial taking place in the UK and the US, offering a specific group of up to 60 children with cancer […]
Kahimmune Therapeutics signs exclusive licensing agreement with Gustave Roussy and SATT Paris-Saclay
Kahimmune Therapeutics, a biotechnology company developing next-generation immuno-oncology therapies, today announces the signing of an exclusive licensing agreement with Gustave Roussy, the European leader in oncology, and SATT Paris-Saclay, experts […]
Dundee to host UK-first immunotherapy trial for cancer patients
The University of Dundee will host the first UK trial of a new way of delivering an immunotherapy treatment, potentially improving access for cancer patients while saving the NHS millions […]
Major study launched to make advanced cancer treatments safer for patients
A major new UK study, led by The Christie NHS Foundation Trust and The University of Manchester, has been launched to help patients with cancer better tolerate cutting-edge immunotherapy treatments […]
A User Guide to Cancer Immunotherapy Conference
Following successful meetings from 2016 to 2024, we are delighted to continue this face-to-face meeting for our User Guide to Cancer Immunotherapy Conference in December 2025. Our updated programme will […]
First UK patient recruited for pioneering lung cancer drug trial at UHNM
The University Hospitals of North Midlands NHS Trust has become the first NHS Trust in the UK to successfully recruit a patient onto a major new international small-cell lung cancer […]
Sheffield bladder cancer patient praises cutting-edge trial
A man with bladder cancer who had a cutting-edge immunotherapy drug injected straight into his tumour is praising a groundbreaking trial which could help future patients avoid bladder removal surgery. […]
Researchers identify new cancer immunotherapy target
UT Southwestern Medical Center researchers in the US have discovered how a hormone interacts with a receptor on the surface of immune cells to shield cancer cells from the body’s […]
